Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pittsburgh
Dana-Farber Cancer Institute
Wake Forest University Health Sciences
University Health Network, Toronto
The Netherlands Cancer Institute
Centre Francois Baclesse
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Jules Bordet Institute
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OHSU Knight Cancer Institute
Icahn School of Medicine at Mount Sinai
SCRI Development Innovations, LLC
University of California, San Francisco
H. Lee Moffitt Cancer Center and Research Institute
The Netherlands Cancer Institute
Fudan University
Shanghai Jiao Tong University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
Institut Cancerologie de l'Ouest
New Mexico Cancer Research Alliance
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Royal Marsden NHS Foundation Trust
New Mexico Cancer Research Alliance
NYU Langone Health
City of Hope Medical Center
Ludwig-Maximilians - University of Munich